Business Context and Reporting Period
This Form 8-K Current Report was filed by Inmune Bio, Inc. on April 25, 2022. The Company is an emerging growth company incorporated in Nevada with its principal executive offices in Boca Raton, Florida. Its common stock trades on The NASDAQ Stock Market LLC under the symbol INMB.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this document. The filing serves solely to announce a scheduled corporate event.
Guidance, Outlook, and Management Commentary
Management announced its intention to participate in the B. Riley Neuro & Ophthalmology Conference, which is being held virtually on April 28, 2022. A press release detailing this event is attached as Exhibit 99.1. No specific financial guidance, risk updates, or unusual items are disclosed in this filing.
Investor Verification Checklist
- Verify the date and time of the B. Riley Neuro & Ophthalmology Conference (April 28, 2022).
- Review the attached press release (Exhibit 99.1) for specific details on management's presentation topics.
- Confirm the Company's status as an emerging growth company for potential reporting exemptions.